NCT07094477 2025-07-30Study of Targeted CD22/CD19 CAR-T Therapy for First-line Consolidation of B-cell LymphomaChinese PLA General HospitalPhase 2 Active not recruiting50 enrolled
NCT05202782 2024-10-16Zanubrutinib and CAR T-cell Therapy for the Treatment of Recurrent or Refractory Aggressive B-cell Non-Hodgkin's Lymphoma or Transformed Indolent B-cell LymphomaNorthwestern UniversityPhase 2 Active not recruiting24 enrolled